Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disorder of the central nervous system (CNS) that can cause cognition, mobility, and sensory impairments. It is considered one of the most common non-traumatic causes of disability in the world. The aim of the present article was to review the clinical evidence related to medicinal plants in the management of MS symptoms.
Due to Israel’s extensive experience with Medical Cannabis policy and its pioneering research, many consider Israel to be a leading actor in the global Medical Cannabis arena. It is therefore possible that other countries will follow Israel’s lead in its path to the biomedicalization of cannabis.